共 50 条
- [41] Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study Clinical Rheumatology, 2017, 36 : 191 - 197
- [45] Clinical profile and evolution of patients with juvenile-onset Behçet’s syndrome over a 25-year period: insights from the AIDA network Internal and Emergency Medicine, 2021, 16 : 2163 - 2171
- [46] Post-remission retinal microvascular and choroidal thickness changes in eyes with Behḉet’s disease posterior uveitis: an OCTA longitudinal study International Ophthalmology, 2021, 41 : 4163 - 4174
- [47] Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behçet's disease Rheumatology International, 2004, 24 : 212 - 216
- [49] C-reactive protein/albumin ratio as an indicator of disease activity in Behçet’s disease and human leukocyte antigen-B27-associated uveitis Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 1985 - 1992
- [50] An open-label, prospective, single-arm study of switching from infliximab to cyclosporine for refractory uveitis in patients with Behçet’s disease in long-term remission Japanese Journal of Ophthalmology, 2021, 65 : 843 - 848